Advanced Search


Study ID Status Title Patient Level Data
201360 Not yet recruiting HO-14-14418 - Outcomes of first-line pazopanib and sunitinib users and sequential use of pazopanib followed by mTORi therapy among patients with advanced/metastatic renal cell carcinoma in a U.S. community oncology setting.
201362 Completed Administrative database study describing the prevalence of CVD in COPD patients, its impact on exacerbations and health care utilization.
201363 Completed Treatment Pathways in an Inception Lupus Cohort in Atlantic Canada
201364 Active, Not Recruiting Active Lupus in Canada
201365 Recruiting Special Drug Use Investigation of LAMICTAL Tablets in Patients with Epilepsy (Investigation on Switching to Monotherapy)
201373 Completed Characterization of patients with Chronic Lymphocytic Leukemia in British Columbia, Canada using a province-wide CLL database
201376 Active, Not Recruiting Understanding Current Patterns of Care and Planning for the Future – A Retrospective Observtional Study in Melanoma
201378 Completed A randomized, double-blind, double-dummy, parallel group, multicenter study of once daily Fluticasone Furoate/Vilanterol 100/25 mcg Inhalation Powder, twice daily Fluticasone Propionate/Salmeterol 250/50 mcg Inhalation Powder, and twice daily Fluticasone Propionate 250 mcg Inhalation Powder in the treatment of persistent asthma in adults and adolescents already adequately controlled on twice-daily inhaled corticosteroid and long-acting beta2 agonist
201379 Active, Not Recruiting Patterns of Care for Patients with Metastatic Renal Cell Carcinoma in a United States Population
201390 Active, Not Recruiting Impact of Disease Activity on Mortality and Damage Progression in Systemic Lupus Erythematosus (SLE) Patients with Active Disease despite Standard of Care in the Toronto Lupus Cohort
201393 Completed PGx7572: An Exploratory Investigation of CYP2D6 Activity and Efficacy of tafenoquine and primaquine in TAF112582 Part 1
201398 Completed An Exploratory Meta-Analysis of the Efficacy of Dolutegravir across Subgroups
201401 Active, Not Recruiting Prevalence of the metabolic syndrome among men with and without benign prostatic hyperplasia
201402 Completed A Randomised Placebo-controlled Study to Evaluate the Effects of GSK2256294 Following Repeat Dosing on Pulmonary Artery Pressure in Healthy Volunteers Under Normoxic and Hypoxic Conditions Study Listed on
201410 Recruiting A 52-week open-label (sponsor-blind), randomized, active-controlled, parallel-group, multi-center study to evaluate the efficacy and safety of daprodustat compared to recombinant human erythropoietin in subjects with anemia associated with chronic kidney disease who are initiating dialysis
201426 Completed PRJ2250: Survey of patient and prescriber understanding of risks associated with TROBALT
201431 Not yet recruiting Adherence to Dabrafenib plus Trametinib in subjects with BRAF V600 mutant unresectable or metastatic melanoma
201435 Completed A randomised, multi-centre, open label, cross-over non-inferiority study to evaluate efficacy, safety and tolerability of Neumoterol 400 and Symbicort Forte in adults with asthma
201436 Completed A Randomized, Open-label Study to Evaluate the Immunogenicity of Anthrax Vaccine Adsorbed Alone or Concomitantly with Raxibacumab (GSK3068483)
201450 Recruiting ENCRUSE ELLIPTA Drug Use Investigation
201461 Withdrawn A Randomised, Two Treatment, Four-Way Cross-Over (Replicate Design), Two Sequence, Repeat Dose Study in Patients with Moderate Asthma to Compare Pharmacokinetics and Pharmacodynamic Effects of Fluticasone Propionate and Salmeterol Delivered via the Low Airflow Resistance Fluticasone Propionate/Salmeterol (100/50 mcg) ROTAHALER Inhaler Relative to Fluticasone Propionate/Salmeterol (100/50 mcg) Delivered via the DISKUS Inhaler
201463 Completed Measurement of neutrophil retention in the lung in vivo, using autologous labelled neutrophils, in healthy subjects following lipopolysaccharide or saline challenge and patients with chronic obstructive pulmonary disease (COPD)
201464 Suspended A multiple treatment session, open label phase 2 clinical study of GSK2398852 administered following and together with GSK2315698 in cohorts of patients with cardiac amyloidosis
201465 Completed A Phase I Trial to Evaluate Safety and Efficacy of Topically Applied GSK2981278 Ointment in a Psoriasis Plaque Test Study Listed on
201474 Completed A Patient Preference Evaluation Study of Fluticasone Furoate Nasal Spray and Mometasone Furoate Nasal Spray in Subjects with Allergic Rhinitis Study Listed on



For more information on this register please email

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party. is a database that provides summary protocol information for ongoing clinical trials. is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.